Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 121, 2016 - Issue 3
Journal homepage
985
Views
11
CrossRef citations to date
0
Altmetric
Case Report

The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy

Nadia Sawicka-GutajDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland;
,
Maciej MachaczkaHematology Center Karolinska and Department of Medicine at Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; Correspondence[email protected]
,
Izabela Kulińska-NiedzielaHeliodor Swiecicki Clinical Hospital, Ophthalmology Outpatient Clinic, Poznan University of Medical Sciences, Poznan, Poland;
,
Jadwiga Bernardczyk-MellerDepartment of Ophthalmology, NZOZ ‘OCU SERVICE’, Poznan, Poland;
,
Paweł GutajDepartment of Obstetrics and Women’s Diseases, Poznan University of Medical Sciences, Poznan, Poland
,
Jerzy SowińskiDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland;
&
Marek RuchałaDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland;
show all
Pages 192-195 | Received 09 Nov 2015, Accepted 22 Feb 2016, Published online: 11 Apr 2016

References

  • Zimran A. How I treat Gaucher disease. Blood 2011;118:1463–71.
  • Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 2008;29:567–83.
  • Machaczka M, Markuszewska-Kuczyńska A, Regenthal S, Jurczyszyn A, Gałązka K, Wahlin BE, et al. Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1. Pol Arch Med Wewn 2014;124:587–92.
  • Markuszewska-Kuczyńska A, Klimkowska M, Regenthal S, Bulanda A, Kämpe Björkvall C, Machaczka M. Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1. Folia Histochem Cytobiol 2015;53:62–9.
  • Tylki-Szymańska A, Vellodi A, El-Beshlawy A, Cole JA, Kolodny E. Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis 2010;33:339–46.
  • Machaczka M, Hast R, Dahlman I, Lerner R, Klimkowska M, Engvall M, et al. Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution. Ups J Med Sci 2012;117:28–34.
  • Weiss K, Gonzalez AN, Lopez G, Pedoeim L, Groden C, Sidransky E. The clinical management of type 2 Gaucher disease. Mol Genet Metab 2015;114:110–22.
  • Machaczka M, Klimkowska M, Hägglund H. Effort bruising disclosing Gaucher disease in a 55-year-old non-Jewish woman. J Inherit Metab Dis 2009;32:758–61.
  • Machaczka M, Klimkowska M, Regenthal S, Hägglund H. Gaucher disease with foamy transformed macrophages and erythrophagocytic activity. J Inherit Metab Dis 2011;34:233–5.
  • Machaczka M, Klimkowska M. Novel heterozygous c.798C > G and c.1040T > G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1. Ann Hematol 2014;93:1787–9.
  • Machaczka M, Lorenz F, Kleinotiene G, Bulanda A, Markuszewska-Kuczyńska A, Raistenskis J, et al. Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease. Ups J Med Sci 2014;119:44–9.
  • Machaczka M, Kämpe Björkvall C, Wieremiejczyk J, Paucar Arce M, Myhr-Eriksson K, Klimkowska M, et al. Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3. Arch Immunol Ther Exp (Warsz) 2015;63:65–71.
  • Svennerholm L, Dreborg S, Erikson A, Groth CG, Hillborg PO, Håkansson G, et al. Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations. Prog Clin Biol Res 1982;95:67–94.
  • Tylki-Szymańska A, Keddache M, Grabowski GA. Characterization of neuronopathic Gaucher disease among ethnic Poles. Genet Med 2006;8:8–15.
  • Cogan DG, Chu FC, Gittinger J, Tychsen L. Fundal abnormalities of Gaucher’s disease. Arch Ophthalmol 1980;98;2202–3.
  • Sheck LHN, Wilson CJ, Vincent AL. Analysis of the pre-retinal opacities in Gaucher disease using spectral domain optical coherent tomography. Ophthalmic Genet 2012;33:253–6.
  • Hsing YE, Foster A. Preretinal and posterior vitreous deposits in Gaucher disease. JAMA Ophthalmol 2014;132:992.
  • Wollstein G, Elstein D, Strassman I, Seelenfreund M, Zylbermann R, Zimran A. Preretinal white dots in adult-type Gaucher disease. Retina 1999;19:570–1.
  • Seidova SF, Kotliar K, Foerger F, Klopfer M, Lanzl I. Functional retinal changes in Gaucher disease. Doc Ophthalmol 2009;118:151–4.
  • Shrier EM, Barr CC, Grabowski GA. Vitreous opacities and retinal vascular abnormalities in Gaucher disease. Arch Ophthalmol 2004;122:1395–8.
  • Coussa RG, Roos JCP, Aroichane M, Miron MC, Ospina LH. Progression of retinal changes in Gaucher disease: a case report. Eye (Lond) 2013;27:1331–3.
  • Adhi M, Duker JS. Optical coherence tomography – current and future applications. Curr Opin Ophthalmol 2013;24:213–21.
  • McNeill A, Roberti G, Lascaratos G, Hughes D, Mehta A, Garway-Heath DF, et al. Retinal thinning in Gaucher disease patients and carriers: results of a pilot study. Mol Genet Metab 2013;109:221–3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.